Understanding bone marrow involvement in Fabry disease: Broader clinical implications explored

Fabry disease is a rare genetic disease that falls under the category of lysosomal storage diseases. The estimated prevalence of Fabry disease in the general population is approximately 1 in 40,000 to 1 in 117,000 individuals. It has been found to be more common in certain ethnic groups, such as populations of Ashkenazi Jewish, African-American, and European descent [1,2].